Market Overview

UPDATE: Jefferies & Company Reiterates Buy Rating, Raises PT on Varian Medical Systems

Related VAR
8 Stocks You Should Be Watching Today
Varian's Software Selected By Christie NHS Foundation Trust
Accuray Still Stuck In Med-Tech's Twilight Zone (Seeking Alpha)

In a report published Friday, Jefferies & Company reiterated its Buy rating on Varian Medical Systems (NYSE: VAR), and raised its price target from $65.00 to $68.00.

Jefferies noted, “VAR posted a strong F4Q with beats in revenues, EPS, and orders. Initial F13 guidance calls for 8-9% top-line growth. The strong surge in orders and higher outlook should ease persistent concerns of pressures from potential CMS reimbursement cuts, pricing, and competition.”

Varian Medical Systems closed on Thursday at $58.10.

Latest Ratings for VAR

Apr 2016Brean CapitalMaintainsBuy
Jan 2016JefferiesMaintainsBuy
Jan 2016Barrington ResearchAssumesOutperform

View More Analyst Ratings for VAR
View the Latest Analyst Ratings

Posted-In: Jefferies & CompanyAnalyst Color Price Target Analyst Ratings


Related Articles (VAR)

View Comments and Join the Discussion!